The global protein chip market was valued at $652.8 million in 2020, and is projected to reach $1,367.1 million by 2030, registering a CAGR of 7.5% from 2021 to 2030.
Protein chips, also known as protein microarrays, are miniaturized and parallel assay systems that contain small amounts of purified proteins in a high-density format. They allow simultaneous determination of a great variety of analytes from small amounts of samples within a single experiment.
Protein microarray or chip technology is a process of immobilizing proteins on to a solid slide support and utilizing a miniaturized assay to demonstrate protein interactions that has been developed steadily in past years. It is a powerful methodology in a high-throughput format to analyze thousands of known proteins in a single experiment. Protein microarrays are indispensable tools for proteomic applications, multi-parameter clinical diagnostic tests, and many other fields. Protein chips are used for development of new assay detection of protein-binding properties (protein-protein interaction, protein-peptide interaction, protein-DNA interaction, protein-small molecule interaction, and protein-glycan interaction), profiling monoclonal antibody specificity, biomarker identification, and host-pathogen interactions.
Major factors that impact growth of the protein chip market include increase in global burden of cancer, which has significantly mounted over the past decade as protein chips can be used in detection of particular cancer protein for accurate cancer diagnosis and finalization of treatment therapy. In addition, biomarkers have the potential to improve early diagnosis rate of cancer. However, owing to the drawback of traditional biomarkers and diagnostic methods, they are not an ideal diagnostic tools in clinical practice. Therefore, new biomarkers and simple and efficient test methods such as a smaller sample and miniaturization and protein microarray technology do have great potential in cancer diagnosis. However, complexity of protein microarray (chip) during production and quantification is expected to impede growth of the protein chip market during the forecast period.
The market is expected to witness moderate growth during the forecast period, owing to technological advancements in protein chip and increase in private funding and government grants for R&D in protein chip.
The protein chip market is segmented on the basis of technology, application, end user, and region. By technology, it is divided into analytical microarrays, functional protein microarrays, and reverse phase protein microarrays. The application segment includes diagnostics, proteomics, and antibody characterization. The end user segment includes hospitals & clinics, diagnostic laboratories, academic & research institutes, and pharmaceutical & biotechnological companies. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The prominent players in the market have adopted various strategies for increasing their market share. These include expansion of their geographical presence through collaborations and partnerships and increase in investment in developing long-acting and effective products with lower adverse effects. Major players operating in the protein chip market include Raybiotech Inc, Illumina Inc, Quotient limited, Agilent Technologies, Thermofisher Scientific, Perkin Elmer, Bio-Rad laboratories, Danher Corporation, Merck KGGA, Arrayit Corporation.
North America accounted for the highest share in the protein chip market in 2020, and is expected to dominate during the forecast period. Whereas Asia-Pacific is expected to grow at the highest CAGR.
Protein chips, also known as protein microarrays, are miniaturized and parallel assay systems that contain small amounts of purified proteins in a high-density format. They allow simultaneous determination of a great variety of analytes from small amounts of samples within a single experiment.
Protein microarray or chip technology is a process of immobilizing proteins on to a solid slide support and utilizing a miniaturized assay to demonstrate protein interactions that has been developed steadily in past years. It is a powerful methodology in a high-throughput format to analyze thousands of known proteins in a single experiment. Protein microarrays are indispensable tools for proteomic applications, multi-parameter clinical diagnostic tests, and many other fields. Protein chips are used for development of new assay detection of protein-binding properties (protein-protein interaction, protein-peptide interaction, protein-DNA interaction, protein-small molecule interaction, and protein-glycan interaction), profiling monoclonal antibody specificity, biomarker identification, and host-pathogen interactions.
Major factors that impact growth of the protein chip market include increase in global burden of cancer, which has significantly mounted over the past decade as protein chips can be used in detection of particular cancer protein for accurate cancer diagnosis and finalization of treatment therapy. In addition, biomarkers have the potential to improve early diagnosis rate of cancer. However, owing to the drawback of traditional biomarkers and diagnostic methods, they are not an ideal diagnostic tools in clinical practice. Therefore, new biomarkers and simple and efficient test methods such as a smaller sample and miniaturization and protein microarray technology do have great potential in cancer diagnosis. However, complexity of protein microarray (chip) during production and quantification is expected to impede growth of the protein chip market during the forecast period.
The market is expected to witness moderate growth during the forecast period, owing to technological advancements in protein chip and increase in private funding and government grants for R&D in protein chip.
The protein chip market is segmented on the basis of technology, application, end user, and region. By technology, it is divided into analytical microarrays, functional protein microarrays, and reverse phase protein microarrays. The application segment includes diagnostics, proteomics, and antibody characterization. The end user segment includes hospitals & clinics, diagnostic laboratories, academic & research institutes, and pharmaceutical & biotechnological companies. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The prominent players in the market have adopted various strategies for increasing their market share. These include expansion of their geographical presence through collaborations and partnerships and increase in investment in developing long-acting and effective products with lower adverse effects. Major players operating in the protein chip market include Raybiotech Inc, Illumina Inc, Quotient limited, Agilent Technologies, Thermofisher Scientific, Perkin Elmer, Bio-Rad laboratories, Danher Corporation, Merck KGGA, Arrayit Corporation.
North America accounted for the highest share in the protein chip market in 2020, and is expected to dominate during the forecast period. Whereas Asia-Pacific is expected to grow at the highest CAGR.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the global mass spectroscopy market along with the current trends and future estimations to elucidate the imminent investment pockets.
- A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
- Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the key segments of the industry helps to understand the application and products of protein chip used across the globe.
- Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By Technology
- Analytical Microarrays
- Functional Protein Microarrays
- Reverse Phase Protein Microarrays
By Application
- Diagnostics
- Proteomics
- Antibody Characterization
By End User
- Hospitals & Clinics
- Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & Biotechnological Companies
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
- Agilent Technologies Inc.
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Perkinelmer Inc.
- Bio-Rad Laboratories
- Raybiotech Inc
- Illumina Inc
- Quotient Limited
- Merck KGGA
- Arrayit Corporation
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: PROTEIN CHIP MARKET, BY TECHNOLOGY
CHAPTER 5: PROTEIN CHIP MARKET, BY APPLICATION
CHAPTER 6: PROTEIN CHIP MARKET, BY END USER
CHAPTER 7: PROTEIN CHIP MARKET, BY REGION
CHAPTER 8: COMPANY PROFILES
List of Tables
List of Figures
Companies Mentioned
- Raybiotech Inc
- Illumina Inc
- Quotient limited
- Agilent Technologies
- Thermofisher Scientific
- Perkin Elmer
- Bio-Rad laboratories
- Danher Corporation
- Merck KGGA
- Arrayit Corporation
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 299 |
| Published | October 2021 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 652.8 million |
| Forecasted Market Value ( USD | $ 1367.1 million |
| Compound Annual Growth Rate | 7.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
